migraines
The alliance brings both companies' offerings under a single operating platform.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
The startup plans to use the funding to expand in the U.S.